TP53 and B-cell chronic lymphocytic leukemia: Additionally, we demonstrate the effectiveness of SCH900776 with FLU in TP53-mutated primary CLL cells as well as in a wt-TP53 T-cell leukemia 1 (TCL-1)-driven mouse model of human CLL.